Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome-Reference-Cited by-同舟云学术

Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome

Published:2022-02-17 Issue:2 Volume:1 Page:142-156
ISSN:2731-0590
Container-title:Nature Cardiovascular Research
language:en
Short-container-title:Nat Cardiovasc Res

Author:

Song LouJin,Bekdash Ramsey^ORCID,Morikawa Kumi,Quejada Jose R.,Klein Alison D.,Aina-Badejo Danielle,Yoshida Kazushige,Yamamoto Hannah E.,Chalan Amy,Yang Risako,Patel Achchhe,Sirabella Dario,Lee Teresa M.,Joseph Leroy C.,Kawano Fuun,Warren Junco S.,Soni Rajesh K.,Morrow John P.,Yazawa Masayuki^ORCID

Funder

Columbia University

MEXT | Japan Society for the Promotion of Science

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s44161-021-00016-2.pdf

Reference60 articles.

1. Berridge, M. J., Bootman, M. D. & Roderick, H. L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517–529 (2003).

2. Wagner, S., Maier, L. S. & Bers, D. M. Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death. Circ. Res. 116, 1956–1970 (2015).